Warner, A., Lindenberg, L., Mena, E., Aragon-Ching, J. B., Sena, L. A., Posadas, E. M., Moon, H., Bilusic, M., Marshall, C. H., Lee-Wisdom, K., Hausler, M., Williams, M., Hankin, A., Jolissaint, D., Chesnut, G. T., Figg, W. D., Karzai, F., Choyke, P. L., Madan, R. A., Abel, M. L. (2026). Short-course (3-month) enzalutamide monotherapy in biochemically recurrent prostate cancer (BCR): Preliminary prostate specific membrane antigen tumor volume (PSMA-TV) data.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.e17109